Amedisys, Inc.
Amedisys, Inc. (AMED) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
amed · stock forecast · 28 analysts (3M) · FMP · updated Oct 29, 2025
Analyst Rating & Consensus
Based on 28 Wall Street analysts in the past 3 months
Hold
28 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$190
Consensus
$143
+42.0% upside
Low
$85.00
Median: $162.5 · Last Close: $100.99
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$143.38
42.0% upside
High Target
$190
88.1%
Low Target
$85
-15.8%
Current Price
$100.99
as of today
Based on analyst price targets, the AMED stock price prediction for the next 12 months ranges from $85 to $190. The consensus AMED price forecast of $143.38 implies 42.0% upside from the current price of $100.99.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $101.73 | ↑ 0.74% |
1-day model range: $101.63–$101.84. Peak: $101.84 (+0.74%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $97 | -4.0% |
| 2028 | $95 | -6.3% |
| 2029 | $93 | -7.7% |
| 2030 | $92 | -8.5% |
| 2031 | — | -9.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AMED · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-04-16 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-03-04 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2025-02-12 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2024-07-31 | Deutsche Bank | Downgrade ↓ | Buy→Hold |
| 2024-07-25 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2024-07-01 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2024-04-25 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2024-03-26 | Raymond James | Maintains | Market Perform→Market Perform |
| 2024-03-25 | RBC Capital | Maintains | Outperform→Outperform |
| 2023-09-14 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Amedisys, Inc. (AMED) stock. Of the recent 170 rating actions, 24 were upgrades and 24 were downgrades. 28 analysts currently cover AMED.
Analyst Recommendation Trends
AMED analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.3B
↓ 7.1% YoY
Revenue Next Year
$2.3B
↑ 2.6% YoY
EPS This Year
$2.82
EPS Next Year
$4.38
↑ 55.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast AMED EPS of $2.82 for the current fiscal year, based on estimates from 4 analysts. The AMED revenue forecast is $2.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AMED stock forecast is supported by two independent data sources: analyst consensus ratings from 28 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AMED price target is $143.38 (+42.0% upside), with an analyst consensus of Hold.
The AMED short-term stock prediction for tomorrow is $101.73 (+0.74%). The AMED stock price prediction for 2027 estimates an average of $97. The AMED stock prediction for 2030 projects a range of $91–$93.
Amedisys, Inc. trades on NASDAQ under the ticker AMED. The AMED stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 29% of covering analysts.
Frequently asked questions
AMED forecast · 8 questionsAccording to 28 Wall Street analysts, the average 12-month AMED price target is $143.38, with a high forecast of $190.00 and a low of $85.00. The median price target is shown in the chart above when available. This implies +42.0% potential upside from the current price of $100.99.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.